Insider · CIK 0001681871

ACKERMANN CHRISTINA

Reports to the SEC for 4 companies · LONDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0001681871

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−144K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−64.1K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+72K sh	—	—	72,000
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director	MExercise/Conversion	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−200K sh	—	—	0
2025-08-01	VRNAVerona Pharma plcS Sale	Director	SSale	−1,808 sh	$13.14	−$23.8K	64,072
2025-08-01	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+24K sh	—	—	65,880
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−24K sh	—	—	72,000
2025-05-14	VRNAVerona Pharma plcS Sale	Director	SSale	−40K sh	$8.44	−$338K	41,880
2025-05-14	VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	200,000
2025-05-14	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$1.93	+$77.4K	81,880
2025-04-25	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Director	AAward	+96K sh	—	—	96,000
2024-11-06	VRNAVerona Pharma plcP Purchase	Director	PPurchase	+41.9K sh	$4.74	+$198K	41,880
2024-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+240K sh	—	—	240,000
2023-09-01	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+144K sh	—	—	144,000
2023-03-23	CALCCalciMedica, Inc. · Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−1,429 sh	—	—	0
2023-03-23	CALCCalciMedica, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	+1,429 sh	—	—	1,429
2023-03-01	BLCOBausch & Lomb CorpA Award	Please see remarks	AAward	+28.3K sh	—	—	146,677
2023-03-01	BLCOBausch & Lomb Corp · Non-Qualified Stock Options (right to purchase)A Award	Please see remarks	AAward	+90.7K sh	$17.96	+$1.63M	90,744
2022-07-25	BLCOBausch & Lomb CorpA Award	Please see remarks	AAward	+35K sh	—	—	118,333
2022-06-02	CALCCalciMedica, Inc. · Restricted Stock UnitsA Award	Director	AAward	+20K sh	—	—	20,000
2022-06-02	CALCCalciMedica, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-05-05	BLCOBausch & Lomb CorpA Award	Please see remarks	AAward	+83.3K sh	—	—	83,333
2022-05-05	BLCOBausch & Lomb Corp · Non-Qualified Stock Options (right to purchase)A Award	Please see remarks	AAward	+330K sh	—	—	329,670
2022-03-10	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−839 sh	$22.56	−$18.9K	162,240
2022-03-03	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−6,926 sh	$23.61	−$164K	163,079
2022-02-27	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−2,743 sh	$24.35	−$66.8K	173,011
2022-02-27	BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion	EVP AND GENERAL COUNSEL	MExercise/Conversion	−24.3K sh	$24.35	−$592K	0
2022-02-27	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−3,006 sh	$24.35	−$73.2K	170,005
2022-02-27	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−10.3K sh	$24.35	−$250K	175,754
2022-02-27	BHCBausch Health Companies Inc.M Exercise/Conversion	EVP AND GENERAL COUNSEL	MExercise/Conversion	+24.3K sh	—	—	186,033
2022-02-14	BHCBausch Health Companies Inc. · Restricted Share UnitsA Award	EVP AND GENERAL COUNSEL	AAward	+24.3K sh	—	—	0
2021-08-27	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−5,017 sh	$28.95	−$145K	161,741
2021-06-02	BHCBausch Health Companies Inc. · Non-Qualified Stock Options (right to purchase)M Exercise/Conversion	EVP AND GENERAL COUNSEL	MExercise/Conversion	−60.9K sh	—	—	0
2021-06-02	BHCBausch Health Companies Inc.M Exercise/Conversion	EVP AND GENERAL COUNSEL	MExercise/Conversion	+60.9K sh	$15.32	+$932K	287,956
2021-06-02	BHCBausch Health Companies Inc.S Sale	EVP AND GENERAL COUNSEL	SSale	−121K sh	$31.83	−$3.86M	166,758
2021-06-02	BHCBausch Health Companies Inc.M Exercise/Conversion	EVP AND GENERAL COUNSEL	MExercise/Conversion	+60.3K sh	$14.38	+$868K	227,103
2021-06-02	BHCBausch Health Companies Inc. · Non-Qualified Stock Options (right to purchase)M Exercise/Conversion	EVP AND GENERAL COUNSEL	MExercise/Conversion	−60.3K sh	—	—	0
2021-06-02	CALCCalciMedica, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-03-11	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−796 sh	$32.82	−$26.1K	166,758
2021-03-10	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−22K sh	$32.97	−$724K	167,554
2021-03-08	BHCBausch Health Companies Inc.M Exercise/Conversion	EVP AND GENERAL COUNSEL	MExercise/Conversion	+8,455 sh	—	—	163,534
2021-03-08	BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion	EVP AND GENERAL COUNSEL	MExercise/Conversion	−8,455 sh	—	—	0
2021-03-08	BHCBausch Health Companies Inc.A Award	EVP AND GENERAL COUNSEL	AAward	+26K sh	—	—	189,514
2021-03-03	BHCBausch Health Companies Inc.A Award	EVP AND GENERAL COUNSEL	AAward	+36.3K sh	—	—	155,079
2021-03-03	BHCBausch Health Companies Inc. · Non-qualified Stock Options (right To Purchase)A Award	EVP AND GENERAL COUNSEL	AAward	+52.4K sh	—	—	52,392
2021-03-01	BHCBausch Health Companies Inc.F Tax Payment	EVP AND GENERAL COUNSEL	FTax Payment	−5,367 sh	$31.42	−$169K	118,829
2020-09-24	CALCCalciMedica, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-08-28	BHCBausch Health Companies Inc.A Award	EVP AND GENERAL COUNSEL	AAward	+28.2K sh	—	—	124,196

Recent filings

Accepted (ET)
Oct 84
ACKERMANN CHRISTINA0001104659-25-097941
SEC(opens sec.gov)
Aug 54
ACKERMANN CHRISTINA0001104659-25-074396
SEC(opens sec.gov)
May 164
ACKERMANN CHRISTINA0001104659-25-050043
SEC(opens sec.gov)
Apr 294
ACKERMANN CHRISTINA0001104659-25-041382
SEC(opens sec.gov)
Nov 74
ACKERMANN CHRISTINA0001104659-24-115417
SEC(opens sec.gov)
Apr 304
ACKERMANN CHRISTINA0001104659-24-054951
SEC(opens sec.gov)
Sep 54
ACKERMANN CHRISTINA0001104659-23-098231
SEC(opens sec.gov)
Mar 274
ACKERMANN CHRISTINA0001209191-23-021297
SEC(opens sec.gov)
Mar 34
ACKERMANN CHRISTINA0001127602-23-008771
SEC(opens sec.gov)

Companies

Address

3 MORE LONDON RIVERSIDE

LONDON, X0, SE1 2RE